Literature DB >> 20055593

HIV type 1 molecular epidemiology among high-risk clients attending the Thai Red Cross Anonymous Clinic in Bangkok, Thailand.

Miguel A Arroyo1, Nittaya Phanuphak, Somporn Krasaesub, Sunee Sirivichayakul, Vatcharain Assawadarachai, Kultida Poltavee, Tippawan Pankam, Jintanat Ananworanich, Robert Paris, Sodsai Tovanabutra, Gustavo H Kijak, Francine E McCutchan, Praphan Phanuphak, Jerome H Kim, Mark de Souza.   

Abstract

Several studies have reported an increasing number of non-CRF01_AE infections in high-risk groups in Thailand suggesting a more complex HIV-1 epidemic. This study assessed the complexity of the HIV epidemic among high-risk clients tested for HIV-1 at the Thai Red Cross Anonymous Clinic (TRCAC) between July 1, 2006 and February 28, 2007. HIV-1 genotypes were determined from plasma of infected subjects (n = 401) by the multiregion hybridization assay (MHAbce, v.2). Univariate and multivariate logistic regression analyses were used to determine risk factors associated with HIV prevalence and non-CRF01_AE infection. The estimated overall HIV prevalence was 14.1%: 25.3% among men who have sex with men (MSM), 18.4% among heterosexual women, and 9.6% among heterosexual men. Among the risk factors found to be associated with HIV prevalence were age (25-29 years), risk behavior (MSM), marital status (not single), education (less than high school), and inconsistent condom use. Overall, non-CRF01_AE strains accounted for 18.9% of the infections: 25.3% among MSM and 14.8% and 20.4% among heterosexual women and men, respectively. Our results indicate a concentrated and genetically complex HIV epidemic among Thai MSM. These findings advocate for targeted intervention and prevention measures among high-risk populations in Thailand.

Entities:  

Mesh:

Year:  2010        PMID: 20055593     DOI: 10.1089/aid.2009.0150

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  12 in total

Review 1.  Global epidemiology of HIV infection in men who have sex with men.

Authors:  Chris Beyrer; Stefan D Baral; Frits van Griensven; Steven M Goodreau; Suwat Chariyalertsak; Andrea L Wirtz; Ron Brookmeyer
Journal:  Lancet       Date:  2012-07-20       Impact factor: 79.321

2.  Molecular evolution of the HIV-1 Thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trial.

Authors:  Gustavo H Kijak; Sodsai Tovanabutra; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Chirapa Eamsila; Prayura Kunasol; Chirasak Khamboonruang; Prasert Thongcharoen; Chawetsan Namwat; Nakorn Premsri; Michael Benenson; Patricia Morgan; Meera Bose; Eric Sanders-Buell; Robert Paris; Merlin L Robb; Deborah L Birx; Mark S De Souza; Francine E McCutchan; Nelson L Michael; Jerome H Kim
Journal:  J Virol       Date:  2013-04-10       Impact factor: 5.103

3.  Central nervous system viral invasion and inflammation during acute HIV infection.

Authors:  Victor Valcour; Thep Chalermchai; Napapon Sailasuta; Mary Marovich; Sukalaya Lerdlum; Duanghathai Suttichom; Nijasri C Suwanwela; Linda Jagodzinski; Nelson Michael; Serena Spudich; Frits van Griensven; Mark de Souza; Jerome Kim; Jintanat Ananworanich
Journal:  J Infect Dis       Date:  2012-05-02       Impact factor: 5.226

4.  The spread of HIV in Pakistan: bridging of the epidemic between populations.

Authors:  Muhammad R Khanani; Mehreen Somani; Sadiq S Rehmani; Nazle M C Veras; Marco Salemi; Syed H Ali
Journal:  PLoS One       Date:  2011-07-25       Impact factor: 3.240

5.  Molecular evolution of HIV-1 CRF01_AE Env in Thai patients.

Authors:  Samatchaya Boonchawalit; Duangrat Jullaksorn; Jiraporn Uttiyoung; Amara Yowang; Nongkran Krathong; Sununta Chautrakul; Akifumi Yamashita; Kazuyoshi Ikuta; Amornsak Roobsoong; Sangkom Kanitvittaya; Pathom Sawanpanyalert; Masanori Kameoka
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

6.  Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand.

Authors:  Punnee Pitisuttithum; Supachai Rerks-Ngarm; Valai Bussaratid; Jittima Dhitavat; Wirach Maekanantawat; Swangjai Pungpak; Pravan Suntharasamai; Sirivan Vanijanonta; Sorachai Nitayapan; Jaranit Kaewkungwal; Michael Benenson; Patricia Morgan; Robert J O'Connell; Jeffrey Berenberg; Sanjay Gurunathan; Donald P Francis; Robert Paris; Joseph Chiu; Donald Stablein; Nelson L Michael; Jean-Louis Excler; Merlin L Robb; Jerome H Kim
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

7.  Impact of amino acid substitutions in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 on viral neutralization susceptibility to broadly neutralizing antibodies specific for the CD4 binding site.

Authors:  Piraporn Utachee; Panasda Isarangkura-na-ayuthaya; Kenzo Tokunaga; Kazuyoshi Ikuta; Naokazu Takeda; Masanori Kameoka
Journal:  Retrovirology       Date:  2014-04-23       Impact factor: 4.602

8.  Early infant HIV diagnosis and entry to HIV care cascade in Thailand: an observational study.

Authors:  Wasna Sirirungsi; Woottichai Khamduang; Intira Jeannie Collins; Artit Pusamang; Pranee Leechanachai; Suchada Chaivooth; Nicole Ngo-Giang-Huong; Tanawan Samleerat
Journal:  Lancet HIV       Date:  2016-05-03       Impact factor: 12.767

9.  CRF01_AE-specific neutralizing activity observed in plasma derived from HIV-1-infected Thai patients residing in northern Thailand: comparison of neutralizing breadth and potency between plasma derived from rapid and slow progressors.

Authors:  Sompong Sapsutthipas; Naho Tsuchiya; Panita Pathipavanich; Koya Ariyoshi; Pathom Sawanpanyalert; Naokazu Takeda; Panasda Isarangkura-na-ayuthaya; Masanori Kameoka
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

10.  Brief Report: Prevalence Trend of Transmitted Drug Resistance in a Prospective Cohort of Thai People With Acute HIV Infection.

Authors:  Camilla Muccini; Suteeraporn Pinyakorn; Sunee Sirivichayakul; Eugene Kroon; Carlo Sacdalan; Trevor A Crowell; Rapee Trichavaroj; Jintanat Ananworanich; Sandhya Vasan; Nittaya Phanuphak; Donn J Colby
Journal:  J Acquir Immune Defic Syndr       Date:  2021-08-15       Impact factor: 3.771

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.